Article ID Journal Published Year Pages File Type
10964552 Vaccine 2014 4 Pages PDF
Abstract
Study providers routinely recommended the HPV vaccine for their patients. However, providers made fewer recommendations to vaccinate females ages 9-12 years (which includes the target age for vaccination) compared to older females, and used pre-vaccination assessments not recommended by U.S. guidelines, such as screening test results and number of sexual partners. In order to maximize the public health benefit of the HPV vaccine to prevent cervical cancer, adherence to guidelines is necessary, especially in settings that provide care to medically underserved women.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , ,